Wockhardt balance sheet

As of Mar 2026
Total assets
₹8,615cr+5.9% on Mar 2025
Shareholders' equity
₹5,281cr+13.4% on Mar 2025
Total debt
₹2,125cr+14.3% on Mar 2025
Cash and investments
₹629cr+17.8% on Mar 2025
₹ crore except per share
Tap a line for its trendFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
Non-current assets
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
1,6181,7181,8752,022
671513434414
1,028977953945
14541.053.075.0
1,7081,5201,2881,125
72.053.065.064.0
72.053.065.064.0
477549579608
199195218222
5,9185,5665,4655,475
Current assets
887725640658
4124220.00.0
588661618797
21711250590.0
33.079.024.034.0
51.054.018.026.0
1,3011,3281,165947
418412268309
2,6062,4652,0731,914
91.0104111294
8,6158,1357,6497,683
Equity
81.081.077.072.0
4,8594,2723,2823,282
4,9404,3533,3593,354
341304303308
5,2814,6573,6623,662
Liabilities
1,5181,211891224
53.095.0170226
1,5711,3061,061450
40.029.028.026.0
37.035.035.032.0
64.066.072.078.0
1,7121,4361,196586
6076481,2211,663
563592766867
209496592713
1,3791,7362,5793,243
34.053.039.044.0
6.015.010.022.0
203238163126
1,6222,0422,7913,435
3,3343,4783,9874,021
8,6158,1357,6497,683
Trade payables — MSME split
85.047.0——
478545——
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

WOCKPHARMA₹1,922.90

Wockhardt Ltd.

· Pharma & Health
₹ CrorePeersBIOCONSYNGENEASTERDMGLANDPPLPHARMACOHANCELALPATHLABNATCOPHARMMcap ₹31,151 Cr
View
In ₹ Crore except Per Share
As of
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Non-current Assets
+ Property, Plant & Equipment2,022.01,875.01,718.01,618.01,618.0
+ Capital Work-in-Progress414.0434.0513.0671.0671.0
+ Goodwill945.0953.0977.01,028.01,028.0
+ Other Intangibles75.053.041.0145.0145.0
+ Intangibles under Development1,125.01,288.01,520.01,708.01,708.0
+ Other Non-current Financial Assets64.065.053.072.072.0
Non-current Financial Assets64.065.053.072.072.0
+ Deferred Tax Assets608.0579.0549.0477.0477.0
+ Other Non-current Assets222.0218.0195.0199.0199.0
Total Non-current Assets5,475.05,465.05,566.05,918.05,918.0
Current Assets
+ Inventories658.0640.0725.0887.0887.0
+ Current Investments0.00.0422.0412.0412.0
+ Trade Receivables797.0618.0661.0588.0588.0
+ Cash & Cash Equivalents90.0505.0112.0217.0217.0
+ Other Bank Balances34.024.079.033.033.0
+ Other Current Financial Assets26.018.054.051.051.0
Current Financial Assets947.01,165.01,328.01,301.01,301.0
+ Other Current Assets309.0268.0412.0418.0418.0
Total Current Assets1,914.02,073.02,465.02,606.02,606.0
+ Assets Held for Sale294.0111.0104.091.091.0
Total Assets7,683.07,649.08,135.08,615.08,615.0
Equity
+ Equity Share Capital72.077.081.081.081.0
+ Other Equity / Reserves3,282.03,282.04,272.04,859.04,859.0
Equity — Owners of Parent3,354.03,359.04,353.04,940.04,940.0
+ Minority Interest308.0303.0304.0341.0341.0
Total Equity3,662.03,662.04,657.05,281.05,281.0
Liabilities
+ Borrowings — Non-current224.0891.01,211.01,518.01,518.0
+ Other Non-current Financial Liab226.0170.095.053.053.0
Non-current Financial Liabilities450.01,061.01,306.01,571.01,571.0
+ Provisions — Non-current26.028.029.040.040.0
+ Deferred Tax Liabilities32.035.035.037.037.0
+ Other Non-current Liabilities78.072.066.064.064.0
Non-current Liabilities586.01,196.01,436.01,712.01,712.0
+ Borrowings — Current1,663.01,221.0648.0607.0607.0
+ Trade Payables867.0766.0592.0563.0563.0
+ Other Current Financial Liab713.0592.0496.0209.0209.0
Current Financial Liabilities3,243.02,579.01,736.01,379.01,379.0
+ Provisions — Current44.039.053.034.034.0
+ Current Tax Liabilities22.010.015.06.06.0
+ Other Current Liabilities126.0163.0238.0203.0203.0
Current Liabilities3,435.02,791.02,042.01,622.01,622.0
Total Liabilities4,021.03,987.03,478.03,334.03,334.0
Total Equity & Liabilities7,683.07,649.08,135.08,615.08,615.0
Trade Payables — MSME split
+ Dues to Micro & Small — Current——47.085.085.0
+ Dues to Other Creditors — Current——545.0478.0478.0
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.